Schedule of Segment Reporting Information |
The table below presents certain financial
information of our operating segments for the three months ended March 31, 2020 and 2019 (in thousands):
Segment Reporting for the Quarter Ended March 31, 2020
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
|
Segments Total |
|
|
Corporate(1) |
|
|
Consolidated Total |
|
Revenue from external customers |
|
$ |
9,563 |
|
|
$ |
15,297 |
|
|
|
— |
|
|
$ |
24,860 |
|
|
$ |
— |
|
|
$ |
24,860 |
|
Intercompany revenues |
|
|
207 |
|
|
|
8 |
|
|
|
— |
|
|
|
215 |
|
|
|
— |
|
|
|
— |
|
Gross profit |
|
|
2,745 |
|
|
|
1,895 |
|
|
|
— |
|
|
|
4,640 |
|
|
|
— |
|
|
|
4,640 |
|
Research and development |
|
|
94 |
|
|
|
66 |
|
|
|
66 |
|
|
|
226 |
|
|
|
6 |
|
|
|
232 |
|
Interest income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
56 |
|
|
|
56 |
|
Interest expense |
|
|
(18 |
) |
|
|
(6 |
) |
|
|
— |
|
|
|
(24 |
) |
|
|
(96 |
) |
|
|
(120 |
) |
Interest expense-financing fees |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(68 |
) |
|
|
(68 |
) |
Depreciation and amortization |
|
|
264 |
|
|
|
77 |
|
|
|
— |
|
|
|
341 |
|
|
|
5 |
|
|
|
346 |
|
Segment income (loss) before income taxes |
|
|
1,547 |
|
|
|
1,318 |
|
|
|
(66 |
) |
|
|
2,799 |
|
|
|
(1,477 |
) |
|
|
1,322 |
|
Income tax expense |
|
|
(14 |
) |
|
|
— |
|
|
|
— |
|
|
|
(14 |
) |
|
|
— |
|
|
|
(14 |
) |
Segment income (loss) |
|
|
1,533 |
|
|
|
1,318 |
|
|
|
(66 |
) |
|
|
2,785 |
|
|
|
(1,477 |
) |
|
|
1,308 |
|
Expenditures for segment assets |
|
|
679 |
|
|
|
214 |
|
|
|
— |
|
|
|
893 |
|
|
|
3 |
|
|
|
896 |
(2) |
Segment Reporting for the Quarter Ended March 31, 2019
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
|
Segments Total |
|
|
Corporate(1) |
|
|
Consolidated Total |
|
Revenue from external customers |
|
$ |
9,905 |
|
|
$ |
1,803 |
|
|
|
— |
|
|
$ |
11,708 |
|
|
$ |
— |
|
|
$ |
11,708 |
|
Intercompany revenues |
|
|
2 |
|
|
|
21 |
|
|
|
— |
|
|
|
23 |
|
|
|
— |
|
|
|
— |
|
Gross profit/(negative) gross profit |
|
|
2,957 |
|
|
|
(456 |
) |
|
|
— |
|
|
|
2,501 |
|
|
|
— |
|
|
|
2,501 |
|
Research and development |
|
|
147 |
|
|
|
— |
|
|
|
74 |
|
|
|
221 |
|
|
|
6 |
|
|
|
227 |
|
Interest income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
81 |
|
|
|
81 |
|
Interest expense |
|
|
(17 |
) |
|
|
(9 |
) |
|
|
— |
|
|
|
(26 |
) |
|
|
(61 |
) |
|
|
(87 |
) |
Interest expense-financing fees |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(10 |
) |
|
|
(10 |
) |
Depreciation and amortization |
|
|
237 |
|
|
|
78 |
|
|
|
— |
|
|
|
315 |
|
|
|
8 |
|
|
|
323 |
|
Segment income (loss) before income taxes |
|
|
1,875 |
|
|
|
(1,012 |
) |
|
|
(74 |
) |
|
|
789 |
|
|
|
(1,300 |
) |
|
|
(511 |
) |
Income tax expense |
|
|
(39 |
) |
|
|
— |
|
|
|
— |
|
|
|
(39 |
) |
|
|
— |
|
|
|
(39 |
) |
Segment income (loss) |
|
|
1,836 |
|
|
|
(1,012 |
) |
|
|
(74 |
) |
|
|
750 |
|
|
|
(1,300 |
) |
|
|
(550 |
) |
Expenditures for segment assets |
|
|
222 |
|
|
|
2 |
|
|
|
— |
|
|
|
224 |
|
|
|
— |
|
|
|
224 |
(2) |
(1) Amounts reflect the activity
for corporate headquarters not included in the segment information.
(2) Net of financed amount of $82,000
and $4,000 for the three month ended March 31, 2020 and 2019, respectively.
|